Literature DB >> 10075936

A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.

J M Stommel1, N D Marchenko, G S Jimenez, U M Moll, T J Hope, G M Wahl.   

Abstract

Appropriate subcellular localization is crucial for regulating p53 function. We show that p53 export is mediated by a highly conserved leucine-rich nuclear export signal (NES) located in its tetramerization domain. Mutation of NES residues prevented p53 export and hampered tetramer formation. Although the p53-binding protein MDM2 has an NES and has been proposed to mediate p53 export, we show that the intrinsic p53 NES is both necessary and sufficient for export. This report also demonstrates that the cytoplasmic localization of p53 in neuroblastoma cells is due to its hyperactive nuclear export: p53 in these cells can be trapped in the nucleus by the export-inhibiting drug leptomycin B or by binding a p53-tetramerization domain peptide that masks the NES. We propose a model in which regulated p53 tetramerization occludes its NES, thereby ensuring nuclear retention of the DNA-binding form. We suggest that attenuation of p53 function involves the conversion of tetramers into monomers or dimers, in which the NES is exposed to the proteins which mediate their export to the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075936      PMCID: PMC1171253          DOI: 10.1093/emboj/18.6.1660

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  86 in total

1.  Regulation of the specific DNA binding function of p53.

Authors:  T R Hupp; D W Meek; C A Midgley; D P Lane
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

2.  The p53 protein is an unusually shaped tetramer that binds directly to DNA.

Authors:  P N Friedman; X Chen; J Bargonetti; C Prives
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

3.  Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.

Authors:  M Fritsche; C Haessler; G Brandner
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

4.  The p53-mdm-2 autoregulatory feedback loop.

Authors:  X Wu; J H Bayle; D Olson; A J Levine
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

5.  Analysis of p53 quaternary structure in relation to sequence-specific DNA binding.

Authors:  P Hainaut; A Hall; J Milner
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

6.  Sequence-specific transcriptional activation is essential for growth suppression by p53.

Authors:  J A Pietenpol; T Tokino; S Thiagalingam; W S el-Deiry; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

7.  Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.

Authors:  U M Moll; G Riou; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

8.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.

Authors:  J D Oliner; J A Pietenpol; S Thiagalingam; J Gyuris; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

9.  Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.

Authors:  X F Sun; J M Carstensen; H Zhang; O Stål; S Wingren; T Hatschek; B Nordenskjöld
Journal:  Lancet       Date:  1992-12-05       Impact factor: 79.321

10.  Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants.

Authors:  T D Halazonetis; A N Kandil
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more
  233 in total

1.  Stress signals utilize multiple pathways to stabilize p53.

Authors:  M Ashcroft; Y Taya; K H Vousden
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  MdmX protects p53 from Mdm2-mediated degradation.

Authors:  M W Jackson; S J Berberich
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

3.  Nuclear export signal located within theDNA-binding domain of the STAT1transcription factor.

Authors:  K M McBride; C McDonald; N C Reich
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

4.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 5.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

Review 6.  Hsp70 interactions with the p53 tumour suppressor protein.

Authors:  M Zylicz; F W King; A Wawrzynow
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

7.  c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.

Authors:  R V Sionov; S Coen; Z Goldberg; M Berger; B Bercovich; Y Ben-Neriah; A Ciechanover; Y Haupt
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

8.  The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation.

Authors:  J T Zilfou; W H Hoffman; M Sank; D L George; M Murphy
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

9.  Interaction of HCF-1 with a cellular nuclear export factor.

Authors:  Shahana S Mahajan; Markus M Little; Rafael Vazquez; Angus C Wilson
Journal:  J Biol Chem       Date:  2002-09-15       Impact factor: 5.157

10.  A nuclear export signal within the high mobility group domain regulates the nucleocytoplasmic translocation of SOX9 during sexual determination.

Authors:  Stephan Gasca; Joaquin Canizares; Pascal De Santa Barbara; Catherine Mejean; Francis Poulat; Philippe Berta; Brigitte Boizet-Bonhoure
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.